Drug Database
Back to search

Belgium· BE-AMP-SAM220263-00

Muphoran 208 mg

A fotemustin product containing fotemustine, registered in Belgium by Servier Benelux. The same ATC class is registered in 2 of our 19 countries.

ATC L01AD05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedMuphoran 208 mgATCL01AD05REGISTER NO.BE-AMP-SAM220263-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fotemustineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Fotemustin is registered in 2 of 19 countries.

Countries holding a registration under ATC L01AD05 (fotemustin), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 2 of them publish a price we can compare per daily dose
Search fotemustin products by name

Fotemustin · ATC L01AD05

2 / 19 countries

  • Belgiumprice
  • Franceprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Fotemustine
Manufacturer
Servier Benelux
Country
Belgium (BE)
ATC code
L01AD05
ATC class
Fotemustin
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    2200632
  • be_apb
    0780890

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Fotemustin in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fotemustin products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • France · Muphoran

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/38aa25f0-ec2c-45e8-b174-0745dae931d3
GET /v1/drugs/38aa25f0-ec2c-45e8-b174-0745dae931d3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder and solvent for solution for infusion",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Muphoran 208 mg",
  "name_fr": "Muphoran 208 mg",
  "name_nl": "Muphoran 208 mg",
  "amp_code": "SAM220263-00",
  "strengths": [
    "208.0000",
    "208.0000",
    "3.3500"
  ],
  "pack_count": 1,
  "substances": [
    "Fotemustine",
    "Ethanol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Fotemustine",
  "authorisation_numbers": [
    "BE220263"
  ]
}
API referenceMCP serverPlans

See everything about fotemustin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console